Inclusion Criteria:  Diagnosis of castration-resistant metastatic prostate cancer diagnosed in the period between January 2014 and December 2017.  Exclusion Criteria:  Diagnosis of localized or locally advanced or metastatic disease sensitive to castration; Patients with medical records filled with incomplete data that make it impossible to evaluate the treatment received.